Flen Health and AGC Biologics Advance Enzyme Wound Therapy
Heidelberg, Germany, September 24, 2026 Flen Health has selected AGC Biologics as its contract development and manufacturing organization (CDMO)...
biopharmaceutical manufacturing
Advertisement
CelluPro Gains EXCiPACT GMP Certification in China
Yantai, China — September 7, 2026 CelluPro, Ltd. announced that it has received EXCiPACT™ GMP Certification for Pharmaceutical Auxiliary...
Alvotech Expands Biosimilar Reach With Lotus Partnership
Reykjavik, Iceland, August 21, 2026 Alvotech, a biotechnology company focused on the development and manufacture of biosimilar medicines, has...
SK pharmteco Showcases Global CDMO Manufacturing at CPHI
Rancho Cordova, California, USA, August 21, 2026 SK pharmteco, a global contract development and manufacturing organization (CDMO), has announced...
Genprex Advances Diabetes Gene Therapy Manufacturing Scale-Up
AUSTIN, Texas, August 18, 2026 Genprex, Inc. has entered into a development and manufacturing agreement with a leading U.S.-based...
Advertisements
NueCell Bio Launches GMP Cell Therapy Development Platform
San Diego, California, August 5, 2026 NueCell Bio has officially launched as a specialized cell therapy science and development...
Nova Biomedical Expands Cell Line Development Platform
WALTHAM, Mass., July 24, 2026 Nova Biomedical has announced the acquisition of certain assets of NanoCellect, a recognized developer...
AstraZeneca’s Etcamah Approved for First-Line Breast Cancer
CAMBRIDGE, UK, July 23, 2026 AstraZeneca has secured European Commission approval for Etcamah (camizestrant) in combination with a CDK4/6...
Repligen’s $1.5B BioLife Deal Expands CGT Portfolio
WALTHAM, Mass. & BOTHELL, Wash., July 22, 2026 Repligen Corporation has announced a definitive agreement to acquire BioLife Solutions...
BeOne Medicines Scales Cancer Drug Production in the U.S.
San Carlos, Calif., July 23, 2026 BeOne Medicines announced a $300 million expansion of its flagship Princeton West Innovation...
Advertisement
